Cargando…

A new metabolic signature contributes to disease progression and predicts worse survival in melanoma

Metabolic reprogramming is a common hallmark of tumor cells and is a crucial mediator of resistance toward anticancer therapies. The pattern of a metabolism-related signature in melanoma remains unknown. Here, we explored the role of a multi-metabolism-related gene signature in melanoma.We used the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Mengdi, Zhuang, Binyu, Dai, Xiao, Zhang, Liang, Zhao, Fangqing, You, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291831/ https://www.ncbi.nlm.nih.gov/pubmed/33084485 http://dx.doi.org/10.1080/21655979.2020.1822714

Ejemplares similares

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma
por: Liang, Chengcai, et al.
Publicado: (2021)

Worse survival of invasive melanoma patients in men and “de novo” lesions()()
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2020)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Neoadjuvant Chemoradiotherapy Does Not Contribute to Worse Survival in Pathological Node-Negative Rectal Cancer
por: Huang, Yong, et al.
Publicado: (2021)

A twelve-gene signature for survival prediction in malignant melanoma patients
por: Song, Le-Bin, et al.
Publicado: (2020)

Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer
por: Ren, Mengdi, et al.
Publicado: (2022)

Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization
por: Cui, Zhiwei, et al.
Publicado: (2023)

Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis
por: Yamamoto, Yosuke, et al.
Publicado: (2020)

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma
por: Tarhini, Ahmad A, et al.
Publicado: (2014)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
por: Zhou, Jiayu, et al.
Publicado: (2018)

Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients
por: Lu, Tailiang, et al.
Publicado: (2022)

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients
por: Xue, Meijuan, et al.
Publicado: (2019)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients
por: Rotte, Anand, et al.
Publicado: (2013)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

Presence of CD133‐positive circulating tumor cells predicts worse progression‐free survival in patients with metastatic castration‐sensitive prostate cancer
por: Yang, Yunjie, et al.
Publicado: (2022)

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
por: Tonneau, Marion, et al.
Publicado: (2022)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
por: Song, Binyu, et al.
Publicado: (2022)

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma
por: Tang, Zhongjun, et al.
Publicado: (2021)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum]
Publicado: (2019)

High serum MMP-14 predicts worse survival in gastric cancer
por: Kasurinen, Aaro, et al.
Publicado: (2018)

Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs
por: Zhou, Fei, et al.
Publicado: (2018)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
por: Song, Binyu, et al.
Publicado: (2022)

Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma
por: Wu, Liuxing, et al.
Publicado: (2021)

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients
por: Adamik, Juraj, et al.
Publicado: (2023)

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
por: Krebs, Franziska K., et al.
Publicado: (2021)

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
por: Zhao, Mingkun, et al.
Publicado: (2022)

Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma
por: Yang, Jen-Fu, et al.
Publicado: (2022)

Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes
por: Peng, Gaoge, et al.
Publicado: (2022)

Development of a 3-MicroRNA Signature and Nomogram for Predicting the Survival of Patients with Uveal Melanoma Based on TCGA and GEO Databases
por: Zuo, Jun, et al.
Publicado: (2022)

CT‐determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia
por: Wan, Qianyi, et al.
Publicado: (2022)

Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients
por: Lu, Tao, et al.
Publicado: (2019)

Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients
por: Zeng, Ni, et al.
Publicado: (2021)

Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
por: Ping, Shuai, et al.
Publicado: (2022)

Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma
por: Karapetyan, Lilit, et al.
Publicado: (2022)

Increased shedding of HU177 correlates with worse prognosis in primary melanoma
por: Hamilton, Heather K, et al.
Publicado: (2010)

Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma
por: Timerman, Dmitriy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_63n6pb1u8gceo2gpgstau411rp